Kintsugi · Series A
Voice biomarker AI to detect depression and anxiety from speech
Amount
$20M
Round
Series A
Valuation
—
Announced
Feb 2022
Investors
Lead investor
Participating investors
Voice biomarker AI to detect depression and anxiety from speech
Amount
$20M
Round
Series A
Valuation
—
Announced
Feb 2022
Lead investor
Participating investors